Learning about heart and lung side effects from radiation for lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study uses data from patients with early-stage lung cancer who received radiation therapy to learn how radiation affects the heart and lungs. The goal is to improve future treatments and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-small cell lung cancer (NSCLC) at stage I, II, or III.
- You were treated with radiation therapy (like 3D-conformal, IMRT, arc therapy, or SBRT), with or without chemotherapy.
- You did not have surgery to remove part of your lung before radiation.
- You are 18 years or older.
- Your medical information needed for the study is available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking back at the medical records of people with early-stage non-small cell lung cancer who had surgery or radiation therapy between 2018 and 2019. The goal is to understand how patients were diagnosed and treated, which may help improve care for others in the future.
This early study tests whether a specific kind of radiation can be safely given to people with newly diagnosed metastatic lung cancer when cure isn’t possible. It’s meant to see how well the treatment can be delivered and how it affects outcomes in a specific genetic group of tumors.
This study looks at how chest radiation treatment affects the heart and lungs in people with certain lung or esophagus cancers. It may help doctors better predict and prevent these side effects during curative (aimed at cure) radiotherapy.
This study monitors how the heart and lungs respond to radiation therapy combined with immunotherapy for locally advanced lung cancer. It aims to learn how well patients tolerate treatment and to detect early signs of side effects.
This trial looks at how radiation for lung, esophageal, or breast cancer affects the heart. It may help doctors reduce heart damage in future patients.
This study tests whether giving radiation to tumors in the chest soon after starting systemic therapy can help prevent symptoms like pain, trouble breathing, or bleeding. It is for people with advanced non-small cell lung cancer that does not have certain gene changes and has high-risk tumors in the chest.
Hear when a new NSCLC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.